Crescendo Biologics Reaches Technical Milestone for a Second Target in Strategic Collaboration with Takeda

Crescendo Biologics Reaches Technical Milestone for a Second Target in Strategic Collaboration with Takeda

View PDF

Crescendo Biologics Appoints Clinical Development Expert, Dr Igor Matushansky, as Non-Executive Director

Crescendo Biologics Appoints Clinical Development Expert, Dr Igor Matushansky, as Non-Executive Director

View PDF

 

Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications

Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications

View PDF

Crescendo Biologics’ Colette Johnston to present at 11th Annual Proteins & Antibodies Congress, London

Crescendo Biologics’ Colette Johnston to present at 11th Annual Proteins & Antibodies Congress, London

view PDF